Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · IEX Real-Time Price · USD
13.50
+0.34 (2.58%)
At close: May 6, 2024, 4:00 PM
13.89
+0.39 (2.89%)
After-hours: May 6, 2024, 7:10 PM EDT
Entrada Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$21.00
Upside
+55.56%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +48.15% | Mar 18, 2024 |
Oppenheimer | Oppenheimer | Buy Initiates $22 | Buy | Initiates | $22 | +62.96% | Jan 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +48.15% | Nov 27, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +85.19% | Sep 22, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +85.19% | Aug 9, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +85.19% | Aug 2, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +85.19% | May 24, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +85.19% | Apr 3, 2023 |
Goldman Sachs | Goldman Sachs | Hold Maintains $13 → $18 | Hold | Maintains | $13 → $18 | +33.33% | Nov 8, 2022 |
Goldman Sachs | Goldman Sachs | Hold Maintains $10 → $13 | Hold | Maintains | $10 → $13 | -3.70% | Aug 16, 2022 |
Goldman Sachs | Goldman Sachs | Hold Maintains $22 → $10 | Hold | Maintains | $22 → $10 | -25.93% | May 24, 2022 |
Evercore ISI Group | Evercore ISI Group | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 24, 2021 |
Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 23, 2021 |
Goldman Sachs | Goldman Sachs | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 23, 2021 |